Concepedia

Prafulla Kerkar

PK

Statistics

Publications

8

Citations

707

H-Index

8

Active since

2006

Affiliations

University of Colorado Denver(Current)

Assistance Publique – Hôpitaux de Paris

Royal Brompton Hospital

Leiden University Medical Center

Université Paris Cité

Prafulla Kerkar is an author at University of Colorado Denver specializing in medicine, cardiovascular disease, and lipid-lowering therapy.

Publications per year

2006–2022

8

Publications

8

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

, , +17

Chromosome 22 microdeletion by F.I.S.H. in isolated congenital heart disease

Harshvardhan Gawde, Z. M. Patel, M. I. Khatkhatey et al. · The Indian Journal of Pediatrics · 2006 · 23 citations

, , +14

1–5 of 8